Verrica Pharmaceuticals Inc. VRCA
3.72 USD -0.19 (-4.86%)
At closeNov 12, 2026, 4:00 PM EST
3.71 -0.01 -0.27%
After hours · Nov 12, 4:00 PM ET
3.72 Day range 4.21
3.08 52-week range 9.82
- YTD
- -55.23%
- 1 year
- -2.62%
VRCA revenue history
Revenue is income from the company’s ordinary business activities.
35,577,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 35,577,000 | 28,011,000 | 370.22% |
| FY 2024 | 2024-12-31 | 7,566,000 | 2,442,000 | 47.66% |
| FY 2023 | 2023-12-31 | 5,124,000 | -3,908,000 | -43.27% |
| FY 2022 | 2022-12-31 | 9,032,000 | -2,968,000 | -24.73% |
| FY 2021 | 2021-12-31 | 12,000,000 | 12,000,000 | Not meaningful |
| FY 2020 | 2020-12-31 | 0 | 0 | Not meaningful |
| FY 2019 | 2019-12-31 | 0 | 0 | Not meaningful |
| FY 2018 | 2018-12-31 | 0 | 0 | Not meaningful |
| FY 2017 | 2017-12-31 | 0 | 0 | Not meaningful |
| FY 2016 | 2016-12-31 | 0 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-05-22T14:42:21.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.